SHEBA MEDICAL CENTER
๐ฟ๐ฆSouth Africa
- Country
- ๐ฟ๐ฆSouth Africa
- Ownership
- Private
- Established
- 1948-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.sheba.co.il
Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers
Phase 2
Completed
- Conditions
- Hereditary Breast and Ovarian Cancer Syndrome
- Interventions
- Behavioral: Inquiry Based Stress Reduction (IBSR) program
- First Posted Date
- 2011-06-07
- Last Posted Date
- 2013-11-25
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 67
- Registration Number
- NCT01367639
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Tel-aviv, Israel
Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder
Phase 3
- Conditions
- SchizophreniaSchizoaffective Disorder
- Interventions
- First Posted Date
- 2011-03-23
- Last Posted Date
- 2011-03-23
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 400
- Registration Number
- NCT01320982
- Locations
- ๐ท๐ด
Clinica de Psihiatrie, Arad, Romania
๐ท๐ดSpitalul Clinic de Psihiatrie "Prof. Dr. Alex. Obregia", Bucuresti, Romania
๐ท๐ดSp. Jud. "Prof. Dr.O. Fodor", Cluj-Napoca, Romania
Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis
Phase 3
Completed
- Conditions
- Ulcerative Colitis
- Interventions
- Dietary Supplement: Curcumin
- First Posted Date
- 2011-03-22
- Last Posted Date
- 2016-02-12
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT01320436
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Ramat Gan, Israel
Virtual Reality Intervention for Stroke Rehabilitation
Not Applicable
Completed
- Conditions
- Stroke
- Interventions
- Other: Virtual RealityOther: Traditional Therapy
- First Posted Date
- 2011-02-25
- Last Posted Date
- 2015-06-23
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 47
- Registration Number
- NCT01304017
The Development Of A Novel Biomarker For Early Identification Of The Individual's State Of Tolerance To Heat
Completed
- Conditions
- Heat StrokeHealthy
- Interventions
- Other: heat tolerance test (HTT)
- First Posted Date
- 2011-02-04
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT01290159
- Locations
- ๐ฎ๐ฑ
Heller Institute of Medical Research, Sheba Medical Center, Tel Hashomer, Israel
Central Hypothyroidism, a Novel Laboratory Measurement
Not Applicable
- Conditions
- Central Hypothyroidism
- First Posted Date
- 2011-01-20
- Last Posted Date
- 2011-02-03
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT01280292
Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder
- First Posted Date
- 2011-01-20
- Last Posted Date
- 2011-01-20
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT01280305
- Locations
- ๐ท๐ด
Spitalul de Psihiatrie Botosani, Botosani, Romania
๐ท๐ดSpitalul Clinic de Psihiatrie "Prof. Dr. Alex. Obregia", Bucuresti, Romania
๐ท๐ดSp. Jud. "Prof. Dr.O. Fodor", Cluj-Napoca, Romania
Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.
Phase 1
- Conditions
- Chronic Hepatitis C
- Interventions
- Biological: Hydroxychloroquine (HCQ), Pegylated Interferon Alpha-2a (Peg-IFN alpha-2a) and Ribavirin
- First Posted Date
- 2011-01-07
- Last Posted Date
- 2011-01-07
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 36
- Registration Number
- NCT01272310
The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Retinitis Pigmentosa
Not Applicable
Completed
- Conditions
- Retinitis Pigmentosa
- Interventions
- Dietary Supplement: Alga Dunaliella BardawilOther: Sugar pillDietary Supplement: Alga Dunaliella Bardawill
- First Posted Date
- 2010-12-08
- Last Posted Date
- 2013-12-20
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 34
- Registration Number
- NCT01256697
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Tel Hashomer, Israel
Saline Injection - Assisted Anesthesia in Eyelid Surgery
Phase 4
- Conditions
- Blepharoptosis
- Interventions
- Procedure: Injection of Saline + Lidocaine/AdrenalineProcedure: Lidocaine/Adrenaline only
- First Posted Date
- 2010-11-11
- Last Posted Date
- 2011-08-09
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT01239498
- Locations
- ๐ฎ๐ฑ
Goldschlager eye institute, Ramat Gan, Israel
๐ฎ๐ฑGoldschleger institute of ophthalmology, Sheba medical center, Ramat Gan, Israel
ยฉ Copyright 2025. All Rights Reserved by MedPath